MESALAZINE

Clinical trials for MESALAZINE explained in plain language.

Never miss a new study

Get alerted when new MESALAZINE trials appear

Sign up with your email to follow new studies for MESALAZINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Could a common pill boost biologic therapy for ulcerative colitis?

Disease control Completed

This study looked at whether adding mesalazine (a standard anti-inflammatory drug) to biologic treatments like vedolizumab or infliximab can improve healing of the colon lining in people with moderate to severe ulcerative colitis. 438 adults took part. The main goal was to see if…

Matched conditions: MESALAZINE

Phase: PHASE4 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control

Last updated May 07, 2026 18:39 UTC

MESALAZINE

Get alerted when new MESALAZINE trials appear

Could a common pill boost biologic therapy for ulcerative colitis?